Tuesday, May 19, 2026

SBE303: The Next-Gen ADC Cancer Drug Revolutionizing Treatment in 2026

Samsung Bioepis presents promising results for SBE303, a next-gen ADC targeting nectin-4, showing improved efficacy and safety in trials.

U.S. Signals 100% Chip Tariffs: Can Seoul Secure Taiwan-Style Exemptions for Samsung and SK hynix?

The U.S. considers high tariffs on memory chips, impacting South Korea's Samsung and SK Hynix, prompting government negotiations for countermeasures.

Chaos on the Field: Euro 2024 Plagued by Safety Issues and Fan Misconduct

The UEFA European Football Championship (Euro) 2024...

Tag: TurboQuant

No posts to display

Top News

- Our Sponsors Ad -

Follow us